Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Neutrophil Gelatinase-associated Lipocalin (NGAL) and Its Association With the No-reflow Phenomenon in ST-elevation Myocardial Infarction

NCT03264859 is registered in ClinicalTrials.gov with Sheba Medical Center as lead sponsor.

NCT NCT03264859
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03264859 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Neutrophil Gelatinase-associated Lipocalin (NGAL) and Its Association With the No-reflow Phenomenon in ST-elevation Myocardial Infarction
Lead sponsor
Sheba Medical Center
Phase
Observational
Overall status
Unknown status
Start date
September 15, 2017
Completion date
October 31, 2018
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

no-reflow phenomenon, stemi - st elevation myocardial infarction